Exposure to UV radiation is an important risk factor for skin cancer for everyone. However, some people are at significantly greater risk, compared to the general population.
The risk of cutaneous melanoma (skin cancer) is more than doubled where there is a family history of the disease in a close relative (a parent, brother, sister or child).
Skin cancer is related to sun exposure, which is a cumulative process that affects whole areas of skin. A previous diagnosis of skin cancer indicates that the affected skin is at increased risk of developing cancer.
A healthy immune system is able to detect and remove abnormal skin cells. Suppression of the immune system - as a result of disease or as a result of medication - removes this protective "umbrella" and increases the risk that an abnormal cell will develop into a full-blown cancer. Daily use of sunscreen is essential for people at high-risk of developing skin cancer
Two types of UV are absorbed by the skin during normal sun exposure: UVA and UVB.
UVB is absorbed by cells close to the skin surface. It damages cellular DNA and causes an inflammation reaction that we know as sunburn. Many cells die as a result of UVB damage. The toxins that are released from dying cells are responsible for the fever that often accompanies sunburn. DNA damage in surviving cells represents an increased risk for the development of skin cancer. UVA is a more deeply penetrating form of UV that is increasingly recognised as a major cause of skin damage and an important risk factor for skin cancer.
A sunscreen must offer efficient protection against both UVA and UVB. It is important to understand that the sun protection factor (SPF) of a sunscreen refers only to the protection offered against UVB. A high SPF sunscreen should also offer a high level of UVA protection to ensure that the risk of skin cancer is minimised.
Actinica is a major advance in sun protection. A highly effective, broad spectrum sunscreen (SPF 30+) suited to patients at risk of skin damage from sun exposure, it protects from both UVA and UVB radiation, with two hours water and sweat resistance.
The liposomal basis of Actinica targets the upper layers of the skin - maximising protection where it is most effective. It contains photostable UV filters and does not contain nano-particles of zinc or titanium.
A unique measured dose dispenser helps patients apply the correct amount to their skin.
Cosmetically acceptable, patients report excellent compliance using Actinica.
The absence of fragrance and PEG emulsifiers ensures the lotion is well tolerated and suitable for all skin types.
